{"name":"Samjin Pharmaceutical Co., Ltd.","slug":"samjin-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"Samjin Pharmaceutical Co., Ltd. is a South Korean pharmaceutical company with a focus on developing innovative treatments. The company has a pipeline of 21 drugs, primarily in early-stage clinical trials, including SA001 in various dosages.","hq":"","founded":0,"employees":"N/A","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQWkpvT1pGOEZIN0RGUzBYSnIySUVXZ1ZwSktrM3RIZVRTMTJzMHB4QnhSb3JKUTBaTDhTS2lNRWdrLVBJY0lWVG84NzVKZHBSWUZER0NKWVhpbnlucjJxMzVDbnc0ZGRUbmk0VHM3aEZOZ1RzSDZLaUItZEZBb0V4ddIBlAFBVV95cUxQb0lDODZPemhRVkhZWHd2bXBMSVZQYXp6Ukx0TXAxTGZCb2Zmb3VoOExEbjdzYlRsUTQzT3VTT3BpQWNRMWVEeXZUWTJ1MG1fUlBBczFWVFdIQ3N0ZlpvLS1vQXdPUFo4dnUwSDlGRTVSR2FNa3RsdjFSUWl6eldFbUZNRGxVRzV3c1U1Qk9wVjN0RVBU?oc=5","date":"2026-04-06","type":"pipeline","source":"Chosunbiz","summary":"Korea pharma shifts to external hires as price cuts push global R&D - CHOSUNBIZ - Chosunbiz","headline":"Korea pharma shifts to external hires as price cuts push global R&D - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilAFBVV95cUxQb0lDODZPemhRVkhZWHd2bXBMSVZQYXp6Ukx0TXAxTGZCb2Zmb3VoOExEbjdzYlRsUTQzT3VTT3BpQWNRMWVEeXZUWTJ1MG1fUlBBczFWVFdIQ3N0ZlpvLS1vQXdPUFo4dnUwSDlGRTVSR2FNa3RsdjFSUWl6eldFbUZNRGxVRzV3c1U1Qk9wVjN0RVBU0gGUAUFVX3lxTFBvSUM4Nk96aFFWSFlYd3ZtcExJVlBhenpSTHRNcDFMZkJvZmZvdWg4TERuN3NiVGxRNDNPdVNPcGlBY1ExZUR5dlRZMnUwbV9SUEFzMVZUV0hDc3RmWm8tLW9Bd09QWjh2dTBIOUZFNVJHYU1rdGx2MVJRaXp6V0VtRk1EbFVHNXdzVTVCT3BWM3RFUFQ?oc=5","date":"2026-04-06","type":"pipeline","source":"Chosunbiz","summary":"Korea pharma shifts to external hires to power R&D and global expansion - CHOSUNBIZ - Chosunbiz","headline":"Korea pharma shifts to external hires to power R&D and global expansion - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE00czdTX2hfbU1TWllCMGJERGhsZjk4VkZ4Y3h2UE1qaTBHQUlKWVJuOFZsd0lKMTRJeU9hREg2czNGSlo4RGdndkw4bFQ5MEd2OWcxeWtZbHFmcmdLY2dabzI0b01LZE13TlhJYll30gFyQVVfeXFMT3Ryb2dfcTN5X2FWYWI1ZUhHakpqMlVRZHhOSG13YWdkMHhfWE0zN1pWWWVYMGNyMzVVS1ExNk9MYWhpVFlKZ0lWMUhoNDI4UHJqSjIyY3lld2M0UUR2TFNSd0NoZWZSSVpNX292ZUVJZEFB?oc=5","date":"2026-01-28","type":"patent","source":"koreabiomed.com","summary":"[JPM 2026] Samjin outlines shift from generics to new drug R&D - koreabiomed.com","headline":"[JPM 2026] Samjin outlines shift from generics to new drug R&D","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiQkFVX3lxTFBvaHhLTnpzcGZhejc3STJqVzBscHRxZ0RvMFMwNFRJamt4V0Q4N1NhMVNGcS1jdENlT01jekdqNnhFZw?oc=5","date":"2025-06-10","type":"deal","source":"코메디닷컴","summary":"AriBio Signs Alzheimer’s Drug Licensing Deal Worth $600 Million with UAE Pharma Company - 코메디닷컴","headline":"AriBio Signs Alzheimer’s Drug Licensing Deal Worth $600 Million with UAE Pharma Company - 코메디닷컴","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigAFBVV95cUxQNHJLNk1CeHR6cDc3WU4xZmhidE5KaVJUT1VQYlBENkhQR29nREMtQ1pJeGZwNmxiRTRKc0FsLVVQNnE1a1VsaXRraDFTakNtQWlNUExWSFBzbWtwNXhZSTJ2WUdnWGVQeVNtTUM0T3QzeEtORXRnVzBnbVVuQUVFNtIBlAFBVV95cUxOU0IzSjAxM1FhUzR4dEVIQURzellkajQ1ZlF1VFhQTEZYZkticXVmX3hEc3hvTGNqZUp2VmUtUmJQREFzdndpcXhkbHhuUFpqN29md19aekhtbFdNYkNFLXFPeE55cmh2bnpMcHNNZ2U1bmc1UlhfUngtY3JWQUJvVkYtaEs1QWpMaWJhSzNYTC05dVBP?oc=5","date":"2025-06-02","type":"deal","source":"Chosunbiz","summary":"GC Biopharma partners with Pfizer Korea to distribute Paxlovid for COVID-19 in South Korea - CHOSUNBIZ - Chosunbiz","headline":"GC Biopharma partners with Pfizer Korea to distribute Paxlovid for COVID-19 in South Korea - CHOSUNBIZ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1mRkZTNVRhZWdfc1I2OUx6cThFeUhFcEtzb0hyTURxZXI2Y1ZNRWtCem9LOUhVUWt4M1gwdGhyQXo2Rko1Umk5ZW4wU1ZmWlhfVUVjNDA0bG5XS3Jjc3JObUo3cFN5cklqaGduSnl30gFyQVVfeXFMTTA1UFZ5QWc3S3VOeWJkcFl1RXdKUE1Rcmpld2l4a3lQU3o3c1FiVi1XY2dpSTI5aFAzLVdqWkVidy1yOWRmcEtRVFZ1Q01hOWdlUHUxZXpVNkMwNDdzaUtLSU43V3MxdnJxRWRvVHVQVkZB?oc=5","date":"2024-12-03","type":"pipeline","source":"koreabiomed.com","summary":"Samjin Pharmaceutical and APITBIO collaborate on ADC development - koreabiomed.com","headline":"Samjin Pharmaceutical and APITBIO collaborate on ADC development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNdTlxWi1lNVZjUzNEdllULXVHVXpsSEJQSjZHSDdDMlVTR1JZQm13TnctVURYcmR4OHN3Y3dMLWgybHg3N245cDA1YzNfNnZoZW5fWlpDWUh2VlZPM19MZElsRXNzbG1KUWptY0FoS0l1U3dvVUV3UmxEZXhmQ2syMW1LOTVJTURDRXd1M3ZSSk83dVB4M2t0a3ZxNDVDNm0wN0VEWGNnSFR3d1p3VS1DYzZVX2JNM2ZzZ3ZzbjhBNy1YemdHbU1nZ001akV2RWE1REVuNUVrRHh4WERJU2lYckVCeVoyMGpCc0ctcEgyV0hOQW16UU83eg?oc=5","date":"2024-03-24","type":"deal","source":"Business Wire","summary":"AriBio Licenses Exclusive Marketing Rights for AR1001 for Alzheimer’s Disease in China for $770 Million USD - Business Wire","headline":"AriBio Licenses Exclusive Marketing Rights for AR1001 for Alzheimer’s Disease in China for $770 Million USD","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTFBkMldFQWl2dXhabDloSmtPOWVHLVZUTW1qbUZwOWw0MmxLOXp6eTVNSUluYUdiYjBJT2JiQmZCOTU3OXJkeU1sRTBQVzNtRm0wQzF5aUkwUkFsakk5bkdELUl2ZFFUSjZTNFhwV0pR?oc=5","date":"2023-01-04","type":"pipeline","source":"KED Global","summary":"Samjin Pharm to undertake joint ADC R&D with Novelty Nobility - KED Global","headline":"Samjin Pharm to undertake joint ADC R&D with Novelty Nobility","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibEFVX3lxTE9zZ3ViTVAwbkZHcy1hOGE5UmxHaHBoUlV3eERsbm9vSG14V2FoV2NQWFJ0UXkxU2FzZ1VZLTMwajJ1SzFvTUdRZERnenh1ZWZtNWJSSnRpbUxhUXlpU1ZKMml6M216SUR2T1VNdtIBcEFVX3lxTE9EOUlkTkotRjdGTEp4eDVBODA3V1RRdlNhZ3hGOWtaVFBfSTZxc2ExcGVGYWtfMVBLb0pNNVV2S3RaVmRDemJFT2d6Z2lXTFFzNWItRlRDTEpvSVN0aHZWUjhoNldfX3VsTzI0SEE3Tjg?oc=5","date":"2019-03-12","type":"pipeline","source":"koreabiomed.com","summary":"Drugmakers to name new CEOs, enhance ownership - koreabiomed.com","headline":"Drugmakers to name new CEOs, enhance ownership","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}